| Cat.No. | Name | Information |
|---|---|---|
| M42296 | Carbonic anhydrase inhibitor 15 | Carbonic anhydrase inhibitor 15 is a carbonic anhydrase inhibitor (Ki: 8.5 nM for hCA II). |
| M42295 | hCA/VEGFR-2-IN-1 | hCA/VEGFR-2-IN-1 is a potent dual Carbonic Anhydrase(CA) IX/XII with Ki values of 4.7 nM and 8.3 nM for hCA XII and hCA IX, respectively. |
| M42294 | HCAIX-IN-1 | HCAIX-IN-1 is a potent and selective HCAIX inhibitor with KIs of 694.9, 126.6, 3.3, 9.8 nM for hCA I, hCA II, hCA IX, hCA XII, respectively. |
| M42293 | hCAIX-IN-18 | hCAIX-IN-18 is an inhibitor of carbonic anhydrase (CA), with Kis of 3.5 nM, 9.4 nM, 43.0 nM and 8.2 nM for hCAI, hCAII, hCAIX, hCAXII, respectively. |
| M39054 | hCAI/II-IN-6 | hCAI/II-IN-6 is an orally active human carbonic anhydrase (CA) inhibitor. hCAI/II-IN-6 selectively inhibits hCA II and hCA VII isoforms with Ki values of 220, 4.9, 6.5 and ＞50000 nM for hCA I, hCA II , hCA VII and hCA XII respectively. hCAI/II-IN-6 shows anticonvulsant activity and anti maximal electroshock (MES) activity in vivo. |
| M30374 | Sultiame | Sultiame is a carbonic anhydrase inhibitor, widely used as an antiepileptic agent. |
| M29708 | EMAC10101d | EMAC10101d is a potent and selective toward hCA II inhibitor, with a Ki of 8.1 nM. |
| M25289 | Girentuximab | Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). |
| M20427 | Benzenesulfonamide | Benzenesulfonamide ia an inhibitor of carbonic anhydrases. |
| M8357 | Dorzolamide | Dorzolamide is a potent carbonic anhydrase II inhibitor with an IC50 value of 0. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
